Emergency contraceptive availability by country
This table includes a list of countries by emergency contraceptive availability.
.
Country | Region | Availability | Over the counter | Non-prescription | Age restriction | Cost | Awareness | Notes |
Afghanistan | Asia | Import only | ||||||
Albania | Europe | - | €15,60 €4,50 | 66-75% | "Currently, Postinor-2 is the only EC brand available in Albania as there is a stock out of NorLevo in the country for unknown reasons." | |||
Algeria | Africa | |||||||
Andorra | Europe | Under 16s require parental consent | €20 – €26 €6,1 – €7,8 | |||||
Angola | Africa | 580 - 2950 AKZ | 23.5% | |||||
Antigua and Barbuda | Caribbean | Some restrictions | ||||||
Argentina | South America | Over 14 | Free at all public hospitals in Buenos Aires | |||||
Armenia | Caucasus | |||||||
Aruba | Caribbean | - | ||||||
Australia | Oceania | - | $20–$30 | 97% | "Pharmacists can refuse supply on religious grounds, but must refer the woman to another supplier" | |||
Austria | Europe | - | €31,90 €12,90–13,50 | ≥84% | Common misconception that it acts like an abortifacient | |||
Azerbaijan | Asia | |||||||
Bahamas | Caribbean | Only available in family planning clinics | ||||||
Bahrain | Middle East | |||||||
Bangladesh | Asia | - | ৳24,00 Free | "Relatively unknown", 2001 | ||||
Barbados | Caribbean | Access restricted due to misinformation | ||||||
Belgium | Europe | - | €24,99 , €8,55–€9,85 | Fully reimbursed under prescription if under 21 | ||||
Belarus | Europe | - | €17 €10 | |||||
Belize | Central America | |||||||
Benin | Africa | |||||||
Bhutan | Asia | Over the counter EC introduced in 2018 | ||||||
Bolivia | South America | - | Bs55.50 | |||||
Bosnia and Herzegovina | Europe | €25,30–30,00 €14,50–22,50 | Anecdotally available without prescription | |||||
Botswana | Africa | |||||||
Brazil | South America | - | Free at most public hospitals, R$35 otherwise | |||||
Brunei | Asia | Possibly due to small population | ||||||
Bulgaria | Europe | None Over 16 | €22,00 €15,00 | ≥84% | ||||
Burkina Faso | Africa | |||||||
Burundi | Africa | 22.9% | Women can be refused service by providers, and it is dissaproved of by church leaders. Many are secretive about contraceptive use. | |||||
Cameroon | Africa | |||||||
Cambodia | Asia | |||||||
Canada | North America | |||||||
Canada | North America | |||||||
Cape Verde | Africa | Possibly due to small population | ||||||
Central African Republic | Africa | |||||||
Chad | Africa | |||||||
Chile | South America | - | ||||||
China | Asia | |||||||
Colombia | South America | |||||||
Comoros | Africa | Import only | ||||||
Congo, Democratic Republic of | Africa | XOF 1200 | 23% | |||||
Costa Rica | Central America | Due to active opposition | ||||||
Croatia | Europe | LNG only available without prescription if over 16 years old | €25,60 €21,40 | |||||
Cuba | Caribbean | |||||||
Curaco | Caribbean | - | ||||||
Cyprus | Europe | - | €29,42 | Only UPA is available due to financial crisis | ||||
Czech Republic | Europe | † | None †Under 17s need a prescription | €24,50 €21,00 | ≥84% | |||
Denmark | Europe | - | €23,36 €12,45 | 45% | ||||
Djibouti | Africa | |||||||
Dominican Republic | Central America | |||||||
East Timor | Oceania | Due to conflict in the region | ||||||
Ecuador | South America | - | Free at public health premises | |||||
Egypt | Africa | |||||||
El Salvador | Central America | |||||||
Equatorial Guinea | Africa | Import only | Pregnant girls are forced to leave school. | |||||
Eritrea | Africa | Import only | ||||||
Estonia | Europe | €18,73 €15,79 | ||||||
Ethiopia | Africa | |||||||
Fiji | Oceania | Import only | ||||||
Finland | Europe | - | €33,60 €18,87 | >90% | Sometimes provided free of charge in hospitals and family planning clinics | |||
France | Europe | €18,88 €6,75 | LNG is free for under 18s. LNG and UPA are free from family planning clinics | |||||
Gabon | Africa | 49% | ||||||
Gambia | Africa | Import Only | ||||||
Georgia | Caucasus | |||||||
Germany | Europe | Parental consent if under 14 years old | €30 €18 | If under 20 years old, free with prescription | - | |||
Ghana | Africa | - | 4-19 Cedis | 64% | ||||
Greece | Europe | - | €25.77 €7 | |||||
Guatemala | Central America | - | ||||||
Guinea-Bissau | Africa | Import only | ||||||
Guinea-Conakry | Africa | |||||||
Guyana | Caribbean | Guy $1000-$2500 | 30% | |||||
Haiti | Caribbean | 19% / 58% | ||||||
Hungary | Europe | Anecdotally easy to get without prescription along borders | ||||||
Honduras | Central America | N/A | N/A | Due to active opposition. Misinformation is spread by the church and politicians that it causes "abortions, infertility and cancer" | ||||
Hong Kong | Asia | |||||||
Iceland | Europe | |||||||
India | Asia | <33% | ||||||
Indonesia | Asia | |||||||
Iran | Asia | |||||||
Iraq | Asia | Import only | ||||||
Ireland | Europe | No age restriction | ||||||
Israel | Middle East | - | ILS 166 ILS 55-100 | |||||
Italy | Europe | |||||||
Ivory Coast | Africa | |||||||
Jamaica | Central America | |||||||
Japan | Asia | |||||||
Jordan | Middle East | |||||||
Kazakhstan | Asia | €15,10 €5,54 | Easy to get without prescription along borders | |||||
Kenya | Africa | - | Ksh200 | 59% | ||||
Kiribati | Polynesia | Import only | ||||||
Kosovo | Europe | |||||||
Kuwait | Asia | |||||||
Kyrgyzstan | Asia | |||||||
Laos | Asia | |||||||
Latvia | Europe | |||||||
Lebanon | Asia | |||||||
Lesotho | Africa | 35% | ||||||
Libya | Africa | Due to conflict in the region | ||||||
Lithuania | Europe | ≥84% | ||||||
Luxembourg | Europe | |||||||
Madagascar | Africa | |||||||
Malawi | Africa | 45% | ||||||
Malaysia | Asia | $1.30-5.00 | ||||||
Maldives | Asia | Import only | ||||||
Mali | Africa | |||||||
Malta | Europe | €37,94 €19,90 | Available since 2016 after a judicial protest from the Women's Rights Foundation There remains a common misconception that it is an abortifacient | |||||
Mauritania | Africa | |||||||
Mauritius | Indian Ocean | |||||||
Mexico | North America | - | Free in family planning centres | 75% | ||||
Micronesia | Oceania | Possibly due to small population | ||||||
Moldova | Europe | €17,03 €8,04 † €4,21 – €4,73 | 62% | † Free for women under 21 and in cases of rape at Youth Friendly Health Centres | ||||
Montenegro | Europe | Possibly due to small population | ||||||
Morocco | Africa | |||||||
Mozambique | Africa | |||||||
Myanmar | Asia | - | Under Ks1,000 | Sale was stopped by authorities during holidays | ||||
Nepal | Asia | Rs. 100-150 | 28% | Sales increased rapidly from 2015, so awareness data is possibly out of date | ||||
Netherlands | Europe | - | €35 €15 | Reimbursed under prescription | ||||
New Zealand | Oceania | - | $35–$50 | |||||
Niger | Africa | 4% | ||||||
Nigeria | Africa | - | ~$1.00 | 30% | ||||
North Korea | Asia | Due to conflict in the region | ||||||
Norway | Europe | - | €32,80 €24,60 | Often free of charge of needy patients | ||||
Oman | Middle East | |||||||
Pakistan | Asia | |||||||
Papa New Guinea | Oceania | Import only | ||||||
Paraguay | South America | Free at some public hospitals, Gs. 35.000 otherwise | ||||||
Peru | South America | - | Free | Many found to be counterfeit | ||||
Philippines | Asia | Due to active opposition | ||||||
Poland | Europe | ≥84% | Common misconception that it acts like an abortifacient | |||||
Portugal | Europe | Free from family planning centres, €12 otherwise | ||||||
Qatar | Middle East | |||||||
Romania | Europe | - | €20 €13 | ≥84% | ||||
Russia | Asia | €7,55 | ≥84% | De facto sold over counter, only LNG available | ||||
Rwanda | Africa | Import only | ||||||
Saint Kitts & Nevis | West Indies | Possibly due to small population | ||||||
Saint Vincent & Grenadines | Caribbean | Import only | ||||||
Samoa | Oceania | † | 4.7% | †Available only at the TTM National Referral Hospital in Apia, reportedly to discourage ‘abuse’ by either nurses or client. | ||||
São Tomé and Príncipe | Africa | Import only | ||||||
Saudi Arabia | Middle East | 6.2% | Prescription may have been available in the past, but it appears to be banned. | |||||
Senegal | Africa | - | $10.36 $7.50 | 13% | ||||
Serbia | Europe | |||||||
Seychelles | Africa | Import only | ||||||
Sierra Leone | Africa | 6.2% | 30% of girls have their first child before turning 18. Pregnant girls are forced to leave school. | |||||
Singapore | Asia | |||||||
Slovakia | Europe | - | €27 €22 | |||||
Slovenia | Europe | |||||||
Solomon Islands | Oceania | Import only | ||||||
Somalia | Africa | Due to conflict in the region | ||||||
South Africa | Africa | R86,68–100,75 | 23% | |||||
South Korea | Asia | |||||||
South Sudan | Africa | Import only | ||||||
Spain | Europe | - | ≥84% | |||||
Sri Lanka | Asia | Rs.90-150 | ||||||
Sudan | Africa | Due to conflict in the region | ||||||
Suriname | South America | |||||||
Sweden | Europe | - | €25 €17 Free from youth centres | |||||
Switzerland | Europe | €32,85 €17,50 | ||||||
Syria | Asia | Import only | ||||||
Taiwan | Asia | |||||||
Tajikistan | Asia | |||||||
Tanzania | Africa | $5.00 | 11.8% | Twenty percent of 15-19-year-old girls become pregnant, and are forced to leave school. | ||||
Thailand | Asia | |||||||
Tonga | Polynesia | Import only | ||||||
Tunisia | Africa | |||||||
Turkey | Asia | €12 | ||||||
Tuvalu | Polynesia | Possibly due to small population | ||||||
UAE | Middle East | N/A | N/A | Banned because of the misconception that it is an abortifacient. | ||||
United Kingdom | Europe | Over 16 without prescription | Free from health care professionals | ≥84% | ||||
United States of America | North America | - | $40–50 USD | 45% | "roughly 1 in ten teens were incorrectly told they were too young to get without a prescription." | |||
Uruguay | South America | Adult only | ||||||
Uzbekistan | Asia | |||||||
Vanuatu | Oceania | 1000 Vatu | Personal experience in Port Vila, Efate 2018 | |||||
Venezuela | South America | † | †Technically available, but rare and prohibitavely expensive due to economic collapse | |||||
Vietnam | Asia | |||||||
West Bank and Gaza | Middle East | Import only | ||||||
Western Sahara | Africa | Due to conflict in the region and a small population | ||||||
Zambia | Africa | Free of charge at public health institutions | 7.5% |